Log in or Sign up for Free to view tailored content for your specialty!
Retina/Vitreous News
Q&A: Susvimo delivers immediate durability after implantation in wet AMD
Nearly 2 years after it voluntarily recalled Susvimo, Genentech recently announced plans to reintroduce the implant.
VIDEO: OTX-TKI for NPDR shows promising safety, tolerability at 48 weeks
In this Healio Video Perspective from the ASRS meeting, Dilsher Dhoot, MD, of California Retina Consultants discusses interim safety and efficacy results for OTX-TKI for the treatment of nonproliferative diabetic retinopathy.
Log in or Sign up for Free to view tailored content for your specialty!
Study: Patient satisfaction increased with remote scribes
Physicians who utilized remote scribes saw an increase in patient satisfaction compared with those who used in-person scribes, according to a study presented at the American Society of Retina Specialists meeting.
Plan, drill to ensure your practice is disaster-ready
Practices should have a plan for disasters and conduct drills to be prepared, according to a speaker at the American Society of Retina Specialists annual meeting.
Literature review highlights environmental impact of intravitreal injections
Intravitreal injections have a large environmental impact, estimated to be around 210 million kg of CO2 equivalent per year in the U.S. alone, according to a presenter at the American Society of Retina Specialists annual meeting.
FDA approves expanded access program for retinitis pigmentosa gene therapy candidate
The FDA approved Ocugen’s expanded access program for the treatment of retinitis pigmentosa with OCU400, according to a press release.
Glove use does not impact post-injection endophthalmitis but affects carbon footprint
Wearing gloves for intravitreal injections does not decrease the risk for endophthalmitis but does take up time and has a significant carbon footprint, according to a study.
VIDEO: Supplemental treatment not needed in two-thirds of eyes that received EYP-1901
In this Healio Video Perspective from the ASRS meeting, Ashkan M. Abbey, MD, of Texas Retina Associates discusses data from the DAVIO 2 trial investigating EYP-1901 for the treatment of wet age-related macular degeneration.
GLP-1s not tied to higher risk for form of optic neuropathy that may cause blindness
Adults using a GLP-1 receptor agonist do not have increased risk for nonarteritic anterior ischemic optic neuropathy, according to data from a retrospective analysis published in Journal of Diabetes Science and Technology.
Establishing vitrectomy parameters may help determine case complexity
Defining intraoperative parameters for vitrectomy may help shed light on the complexity of a case, according to a study presented at the American Society of Retina Specialists meeting.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read